Research Use Only — Confirm to Continue

OptimalDosages.com publishes reference material for laboratory and educational use. Nothing here is medical advice, a prescription, or a recommendation for human administration.

By continuing you confirm you are 21 or older and that you are accessing this material in a research or educational capacity.

Research Use Only · Dosing data compiled from published literature · Not for human or veterinary use

IGF-1 DES Dosage & Reconstitution

DES(1-3) IGF-1. Work out exactly what to draw for your own mix, see the doses used in research, and follow a week-by-week plan. Evidence tier: preclinical.

1Set Up Your Mix

0.4 mg/mL · 400 mcg/mL
All answers assume a standard 1 mL U-100 syringe, where 1 unit = 0.01 mL. That is the usual insulin syringe and the one every number here is based on.

Your Answer — IGF-1 DESYour Answer

25Draw To This Line
0.25That's This Many mL
10Doses In The Vial
0102030405060708090100 U-100 syringe · 1 mL · 100 units draw to 25
1 mg ÷ 2.5 mL = 0.4 mg/mL  →  100 mcg ÷ 0.4 mg/mL = 0.25 mL  →  × 100 = 25 units
Looks good. Draw to 25 units on a 1 mL syringe. That is an easy amount to measure, and this vial gives you 10 doses.

2Week-By-Week Plan — IGF-1 DES

Start low, work up
WhenDoseHow OftenHow Many mLDraw ToNumber Of DosesPeptide Used
Low reported 50 mcg 1× daily 0.125 mL 12.5 u 20 doses
Standard 100 mcg 1× daily 0.25 mL 25 u 10 doses
Upper reported 150 mcg 1× daily 0.375 mL 37.5 u 6 doses
Weeks until the top dose
4 weeks
Peptide used getting there
2.1 mg
Vials you'll need
3 × 1 mg
Once you're at the top dose
4.2 mg / 4 wk · 4.2 vials
Where this plan came from
Built from this peptide's dose range
Where this came from: Built from the doses listed for this peptide below — start at the lowest and step up, using the studies cited on this page. Nobody publishes a week-by-week plan for this peptide, so we built one: the doses are the researched ones shown below, and we simply put them in order from lowest to highest. Treat it as a starting point, not an official schedule.

3Common Doses — IGF-1 DES

worked out for your mix
LevelDoseHow OftenHow Many mLDraw ToDoses In Vial
Weeks 1–2 50 mcg daily 0.125 mL 12.5 u 14 0.7 mg
Weeks 3–4 100 mcg daily 0.25 mL 25 u 14 1.4 mg
Week 5 onward
per 4 weeks from here on
150 mcg daily 0.375 mL 37.5 u 28 4.2 mg
Please read this. These numbers come from published research. They are here as reference, not as instructions. A lot of them come from lab studies rather than studies in people, and some of these peptides have never been given to a person at all.

About IGF-1 DESAbout This Peptide

Growth Factor
Also known as
DES(1-3) IGF-1
Class
Growth Factor
Route
Subcutaneous
Half-life
~20–30 min
Evidence tier
Preclinical

A truncated IGF-1 variant with roughly tenfold higher potency at the receptor but a very short half-life, hence its reputation as a localised agent. Preclinical only.

Buy IGF-1 DESthis peptide

Opens optimal-pep.com in a new tab

Where These Numbers Come From

Preclinical — Preclinical and in-vitro data only — no human dosing trials
DES(1-3)IGF-I — enhanced potency and reduced binding protein affinity Ballard FJ, et al. Journal of Endocrinology, 1989–1996
Establishes the potency and half-life profile.
Find on PubMed ↗

Newest Studies —

Not reviewed by us. This list is pulled straight from Europe PMC as papers are published. Nobody has checked whether these are any good, or whether they change anything above. The dose numbers on this page only ever change after a person reviews the evidence.

More peptides

Browse the full catalogue, or jump to a neighbouring compound.

IGF-1 LR3

An IGF-1 analogue engineered to resist binding-protein sequestration, giving far longer activity than native IGF-1. Carries genuin…

MGF

A splice variant of IGF-1 expressed in muscle after mechanical loading, implicated in satellite cell activation. Extremely short-l…

All 71 peptides

Every compound compared in one table: dose range, how often, half-life and evidence tier.